-

IVI RMA North America Partners with Mid-Iowa Fertility

Leading National Fertility Network Expands Midwest Access to Best-in-Class Science and Patient Outcomes

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, today announced a new partnership with Mid-Iowa Fertility (MIF), central Iowa’s only full-service fertility center and one of only two fertility centers in the state. Financial terms of the private transaction were not disclosed.

“We are thrilled to welcome Mid-Iowa Fertility to the IVI RMA family and bring the best global fertility science to patients in the Hawkeye State,” said Lynn Mason, CEO of IVI RMA North America. “We are always focused on ways to expand access to critical fertility treatments to meet the growing need for care across North America and look forward to helping Iowans realize their dreams of building families.”

Established in 1993 in Clive, Iowa, Mid-Iowa Fertility combines individualized, tailored fertility care with state-of-the-art onsite IVF laboratory, hospital affiliations, and experienced clinical staff. Led by Drs. Donald Young, Brian Cooper, and Trenton Place, who have more than 40 years of combined experience, MIF offers the most advanced, comprehensive infertility diagnosis and treatments and assisted reproductive services available partnering with local and national programs to provide a full suite of third-party reproductive options to patients. The clinic has been a member of Society for Assisted Reproductive Technology (SART) since 1993, and Society for Reproductive Endocrinology and Infertility (SREI) and Society for Reproductive Surgeons since 1998.

“We are excited to join IVI RMA North America, the pioneers of science-based fertility treatment and recognized leaders in patient-centered care,” said Dr. Brian Cooper, newly appointed Medical Director of Mid-Iowa Fertility. “This partnership will allow us to benefit from IVI RMA’s cutting-edge research and global best practices to expand access and continue delivering the latest in reproductive technology to our patients.”

The partnership reinforces IVI RMA North America’s commitment to delivering exceptional, evidence-based, patient-centered fertility care to the greatest number of patients. This brings the total number of locations that IVI RMA North America operates to 69. MIF is one of only two IVF clinics within a 100+ mile radius of Des Moines and serves an area that stretches across three neighboring states. MIF’s 22 full-time employees add to IVI RMA’s Global network of more than 5,000 people across 200+ locations in 15 countries.

About IVI RMA North America

IVI RMA North America, comprising Reproductive Medicine Associates, Boston IVF, and Toronto-based TRIO, spans 24 IVF laboratories and has helped women and couples achieve pregnancies which have led to the birth of over 220,000 babies to date. Pioneers in innovative care, including PGT-A, single embryo transfer, fertility preservation, LGBTQ+ care, and more, the network’s scientists have published over 1,000 papers which have pushed the fertility industry forward. IVI RMA North America is part of IVI RMA Global, the world's leading reproductive medicine group committed to providing evidence-based fertility solutions to patients seeking treatment anywhere in the world. IVI RMA Global employs nearly 6,000 people across 200+ locations in 15 countries. Learn more at rmanetwork.com and ivirma.com.

Contacts

Media Contact
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

IVI RMA North America


Release Versions

Contacts

Media Contact
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

More News From IVI RMA North America

IVI RMA North America Enters New York City Market through Partnership with Island Reproductive Services

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, today announced it has finalized a new partnership with Island Reproductive Services (“IRS” or “the Company”), the only reproductive medicine provider on Staten Island to have a fertility lab and offer comprehensive fertility treatment to its patients. The company’s partners, Dr. Eric Knochenhauer and Dr. Michael Traub, will retain an equity stake in the business and continue servi...

The 2025 World Fertility Awards Names First Legacy Award After IVI RMA Global Founder and Chairman, Prof. Antonio Pellicer

MADRID--(BUSINESS WIRE)--The inaugural World Fertility Awards (WFAs), presented by global media platform Pregnantish, has named its 2025 Legacy Award after Professor Antonio Pellicer, Co-Founder and Executive Chair of the Board of Directors for IVI RMA Global. Prof. Pellicer is a renowned IVF pioneer and one of the most influential figures in reproductive medicine. Recognizing his impact on the field, the eponymous 2025 Prof. Antonio Pellicer Legacy Award will be given to an individual whose sc...

IVI RMA Launches Global Health Social Impact Award to Support Nonprofits Advancing Reproductive Medicine and Maternal Health

MADRID--(BUSINESS WIRE)--IVI RMA Global, the world’s leading platform for reproductive medicine, announced its new Global Health Social Impact Award, which will offer a $50,000 grant to an existing nonprofit project advancing reproductive and maternal health. Eligible organizations are invited to submit their project proposals for consideration by December 31, 2025 on the official award website: https://www.ivirma.com/sustainability/healthimpactawards.html “This award connects the social missio...
Back to Newsroom